A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JDC Ross - International journal of STD & AIDS, 2009 - journals.sagepub.com
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …
[引用][C] A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic …
M HEYSTEK, JDC ROSS - International journal of STD & AIDS, 2009 - pascal-francis.inist.fr
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin
in the treatment of acute, uncomplicated pelvic inflammatory disease CNRS Inist Pascal-Francis …
in the treatment of acute, uncomplicated pelvic inflammatory disease CNRS Inist Pascal-Francis …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JDC Ross - International Journal of STD & AIDS, 2009 - cabdirect.org
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JD Ross - International Journal of STD & AIDS, 2009 - europepmc.org
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek - 2019 - repositorio.pediatria.gob.mx
Descripción: This multicentre, double-blind study was undertaken to demonstrate non-
inferiority of once-daily oral moxifloxacin compared with combination therapy in the …
inferiority of once-daily oral moxifloxacin compared with combination therapy in the …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JDC Ross, PID Study Group - 2009 - pubmed.ncbi.nlm.nih.gov
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JDC Ross - 2009 - cabidigitallibrary.org
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory …
M Heystek, JDC Ross - International Journal of STD & AIDS, 2009 - search.ebscohost.com
This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …
daily oral moxifloxacin compared with combination therapy in the management of acute …